QUEBEC CITY, QUEBEC--(Marketwire - August 29, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the second quarter ended June 30, 2008.
